Personalized Therapy of Molecular Tumor Board Participation With the Guidance of Next Generation Sequencing

NCT03929653 · clinicaltrials.gov ↗
UNKNOWN
Status
500
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Tianjin Medical University Second Hospital